IRIS
COLUCCIA, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.407
AS - Asia 3.062
EU - Europa 2.962
SA - Sud America 800
Continente sconosciuto - Info sul continente non disponibili 309
AF - Africa 146
OC - Oceania 4
AN - Antartide 1
Totale 14.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.300
SG - Singapore 1.174
RU - Federazione Russa 923
CN - Cina 869
IT - Italia 664
BR - Brasile 629
SE - Svezia 399
HK - Hong Kong 334
DE - Germania 221
UA - Ucraina 209
VN - Vietnam 180
FI - Finlandia 170
FR - Francia 137
IN - India 105
GB - Regno Unito 98
BD - Bangladesh 82
CI - Costa d'Avorio 80
AR - Argentina 61
ID - Indonesia 49
CA - Canada 46
IQ - Iraq 36
MX - Messico 31
TR - Turchia 31
CO - Colombia 30
EC - Ecuador 26
SA - Arabia Saudita 26
PK - Pakistan 25
JP - Giappone 24
ZA - Sudafrica 23
VE - Venezuela 22
ES - Italia 20
PH - Filippine 20
BE - Belgio 18
UZ - Uzbekistan 18
IE - Irlanda 17
JO - Giordania 13
PL - Polonia 13
AT - Austria 12
CZ - Repubblica Ceca 12
IR - Iran 12
NL - Olanda 10
TN - Tunisia 10
CL - Cile 9
PE - Perù 8
BO - Bolivia 7
IL - Israele 7
KE - Kenya 7
AZ - Azerbaigian 6
EG - Egitto 6
LT - Lituania 6
NP - Nepal 6
PY - Paraguay 6
SN - Senegal 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
KZ - Kazakistan 5
LB - Libano 5
OM - Oman 5
AL - Albania 4
CR - Costa Rica 4
HR - Croazia 4
JM - Giamaica 4
MA - Marocco 4
MY - Malesia 4
PT - Portogallo 4
RO - Romania 4
SV - El Salvador 4
AU - Australia 3
GE - Georgia 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
KR - Corea 2
NI - Nicaragua 2
QA - Qatar 2
SI - Slovenia 2
UY - Uruguay 2
AQ - Antartide 1
BF - Burkina Faso 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 14.374
Salva come PNG Salva come JPEG
Città #
Fairfield 634
Chandler 602
Ashburn 589
Woodbridge 577
Singapore 572
San Jose 467
Jacksonville 461
Houston 372
Hong Kong 332
Nyköping 327
Seattle 270
Ann Arbor 255
Milan 248
Cambridge 244
Beijing 213
Wilmington 213
Council Bluffs 181
Nanjing 141
Bari 136
New York 135
Lawrence 130
Roxbury 128
Lauterbourg 110
Boardman 89
Rome 89
Dallas 87
Des Moines 84
Los Angeles 83
Abidjan 80
Ho Chi Minh City 72
Helsinki 66
Princeton 57
Inglewood 55
Columbus 51
Santa Clara 50
São Paulo 48
Brooklyn 46
Buffalo 42
Nanchang 42
Hebei 39
Shenyang 33
Jiaxing 32
San Diego 32
Dearborn 29
Hanoi 29
Munich 25
Pune 24
Tokyo 24
Chicago 21
Guangzhou 20
San Francisco 20
Tianjin 19
Moscow 18
Turin 18
Baghdad 17
Belo Horizonte 17
Brussels 17
Dublin 17
Jakarta 17
Shanghai 17
The Dalles 17
Figino 16
Phoenix 16
Rio de Janeiro 16
Tashkent 16
Toronto 15
Changsha 14
Amman 13
Atlanta 13
Boston 13
Brasília 13
Frankfurt am Main 13
Ardabil 12
London 12
Medellín 12
Orem 12
Brno 11
Falkenstein 11
Montreal 11
Mumbai 11
Riyadh 11
Salvador 11
Washington 11
Auburn Hills 10
Chennai 10
Dong Ket 10
Johannesburg 10
Kunming 10
Leawood 10
Quito 10
Bologna 9
Dhaka 9
Jinan 9
Ningbo 9
Santo André 9
Warsaw 9
Wuhan 9
Curitiba 8
Jeddah 8
Ribeirão Preto 8
Totale 9.320
Salva come PNG Salva come JPEG
Nome #
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 726
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature 228
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 205
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 189
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 187
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 186
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 185
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 182
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 173
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 166
Effect of chirality in platinum drugs 166
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 160
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 160
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 157
Mutagenic activity of some platinum complexes: chemical properties and biological activity 155
Biologic activity of platiunum complexes with proflavine 152
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 141
Endothelial cells in the bone marrow of patients with multiple myeloma 139
Antitumour platinum iminoether complexes 135
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 135
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 131
Platinum(II) based anticancer agents with a trans geometry 128
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 128
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 127
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 126
Antitumour platinum iminoether complexes 126
A preclinical overview on gold(III) compounds in the forefront of the targeted anticancer therapy. 126
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 126
Efficacy of 5FU combined to Na[trans-RuCl4(DMSO)Im], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline, and MCa mammary carcinoma 125
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 125
Antitumour ruthenium(II)-dimethylsulfoxide complexes 125
Antitumour platinum-iminoether complexes 124
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 123
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 122
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 122
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 122
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 120
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 119
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 119
Antitumor active trans-platinum compounds 118
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 117
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 116
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 115
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 114
Antitumor activity of trans platinum complexes 114
A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis 113
CITOTOSSICITA' IN VITRO DI ALCUNI MATERIALI DENTALI 112
Effect of isomerism at non-leaving ligands in platinum anticancer drugs 112
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 109
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 109
Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression 108
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 104
null 104
Anttitumor activity of trans-platinum species 104
Current Status of trans-Platinum Compounds in Cancer Therapy 104
In vitro cisplatin effects on phagocyte functions 102
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 102
Trans-Platinum Complexes in Cancer Therapy 101
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 101
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 101
A trans-platinum complex showing higher antitumor activity than the cis congeners 100
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 100
Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications 97
Bone Marrow Fibroblasts and Multiple Myeloma Progression 97
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 97
Salivary up-regulation of PMN chemotaxis and adhesion molecules expression 96
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 96
Complessi antitumorali di platino a geometria trans 95
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 94
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 94
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 94
Ulteriori contributi allo studio dell'interazione cisplatino-DNA 92
null 92
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 92
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 90
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 89
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 88
null 88
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 88
Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA 86
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 86
Na[trans-RuCl4(DMSO)Im]2DMSO: antimetastatic ruthenium 85
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 85
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 84
Screening tests for selecting anticancer metal compounds 83
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 83
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 82
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 81
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 80
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 80
Complessi antitumorali di platino a geometria trans 79
The IS-BioBank project: a framework for biological data normalization, interoperability, and mining for cancer microenvironment analysis 78
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 78
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 77
A new generation of platinum anticancer complexes with trans geometry 77
Trans platinum complexes in cancer therapy: a largely unexplored strategy of identifying novel antitumour platinum drugs 75
Synthesis, crystal structure, spectral properties and in vitro antitumor activity of platinum(II) complexes of 2-acetyl pyridine and pyridine-2-carbaldehyde N(4)-ethyl-thiosemicarbazones 75
Mutagenic activity of some paltinum complexes: Chemical properties and biological activity 75
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 74
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 74
Totale 12.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022645 0 0 1 30 32 33 32 35 44 49 156 233
2022/20231.524 217 144 123 145 196 202 6 194 233 11 22 31
2023/2024565 40 87 25 27 69 183 4 35 12 10 1 72
2024/20251.919 138 30 183 64 46 132 206 137 54 94 294 541
2025/20264.851 564 172 335 486 490 229 434 105 1.105 350 111 470
2026/2027519 105 221 193 0 0 0 0 0 0 0 0 0
Totale 14.691